Physician

Kofi E Sarfo, M.D.

According to 2025 Medicare claims, Kofi Sarfo, M.D. (NPI: 1881695609) practices family practice in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is VISTA MEDICAL ASSOCIATES LLC (NPI: 1962403121) and primary practice location at 89030-4234.

Sarfo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 154 traditional Medicare patients, billed 11,280 HCPCS/CPT codes, and received $2,030,319 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,171 prescription claims across 124 beneficiaries totaling $141,827 in drug costs, led by Ozempic (Semaglutide). 2022 DME data shows 73 claims. Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $377,662 to $2,030,319. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $338,904 and ending at $141,827. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $5,177 to $3,452.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	183	8,760	$377,662
2016	163	5,908	$285,581
2017	166	4,662	$200,774
2018	316	8,791	$594,598
2019	299	7,157	$437,798
2020	204	4,309	$297,302
2021	241	12,808	$772,257
2022	231	15,668	$895,218
2023	247	14,633	$860,329
2024	154	11,280	$2,030,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	4,749	$338,904
2016	197	4,400	$246,093
2017	191	4,223	$222,274
2018	207	3,565	$237,245
2019	199	4,228	$206,063
2020	184	4,092	$201,537
2021	192	6,201	$333,560
2022	151	5,405	$356,430
2023	164	4,264	$322,361
2024	124	2,171	$141,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	60	$2,649
2017	N/R	51	$1,862
2018	N/R	N/R	N/R
2019	N/R	25	$337
2020	N/R	13	$164
2021	13	155	$47,862
2022	N/R	73	$24,257
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	28	85	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	38	239	$59
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	117	6,567	$52
11042	Removal of skin and tissue, 20.0 sq cm or less	34	51	$42
49460	Mechanical removal of obstructive material from stomach, large, or small bowel tube using fluoroscopic guidance	54	2,455	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	23	672	$20,399
Eliquis	Apixaban	24	496	$9,898
Entresto	Sacubitril/Valsartan	11	330	$7,159
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	318	4,613	$5,937
Mometasone Furoate	Mometasone Furoate	11	330	$2,111

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$19	Baxter Healthcare
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kofi E. Sarfo, M.D.?

Tedicare shows public-source Medicare data for Kofi E. Sarfo, M.D. (NPI 1881695609), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kofi E. Sarfo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kofi E. Sarfo, M.D.?

Kofi E. Sarfo, M.D. is linked to VISTA MEDICAL ASSOCIATES LLC (billing NPI 1962403121) in the available physician profile data.

Does Kofi E. Sarfo, M.D. have Open Payments data?

Kofi E. Sarfo, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.